| ? | (A;A) (A;G) (G;G) | 28 |
|---|
 |
[PMID 21638280] 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer
[PMID 15732009] Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
[PMID 19247438] Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
[PMID 19434718] Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
[PMID 19956101] Overview of the Rapid Response data.
[PMID 19956105] Reassessment of the type I diabetes association of the OAS1 locus.
[PMID 20079393] 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
| GET Evidence
|
| OAS1-G162S
|
| aa_change
|
Gly162Ser
|
| aa_change_short
|
G162S
|
| impact
|
not reviewed
|
| qualified_impact
|
Insufficiently evaluated not reviewed
|
| overall_frequency
|
0.451571
|
| summary
|
|
